Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues

Cellular Immunology

Volumn 259, Issue 2, 2009, Pages 150-156

  Yoo, Keon Hee ^a,c   Jang, In Keun ^b   Lee, Myoung Woo ^a   Kim, Hyo Eun ^b   Yang, Mal Sook ^b   Eom, Youngwoo ^b   Lee, Jong Eun ^b   Kim, Young Jin ^b   Yang, Seong Kyu ^a   Jung, Hye Lim ^a   Sung, Ki Woong ^a   Kim, Cheol Woo ^c   Koo, Hong Hoe ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b LifeCord Inc   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

IFN ; Immunomodulation; Indoleamine 2,3 dioxygenase; Mesenchymal stem cells; TNF

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ARTICLE; BONE MARROW; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

ADIPOSE TISSUE; ANTIGENS, CD; BONE MARROW CELLS; CELL PROLIFERATION; CYTOKINES; FETAL BLOOD; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; MESENCHYMAL STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 70349121293     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.06.010     Document Type: Article

References (42)

1. Friedenstein A.J., Petrakova K.V., Kurolesova A.I., and Frolova G.P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6 (1968) 230-247
2. Friedenstein A.J., Chailakhyan R.K., and Gerasimov U.V. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet. 20 (1987) 263-272
3. Owen M. Marrow stromal stem cells. J. Cell Sci. Suppl. 10 (1988) 63-76
4. Caplan A.I. Mesenchymal stem cells. J. Orthop. Res. 9 (1991) 641-650
5. Young R.G., Butler D.L., Weber W., Caplan A.I., Gordon S.L., and Fink D.J. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J. Orthop. Res. 16 (1998) 406-413
6. Wakitani S., Saito T., and Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18 (1995) 1417-1426
7. Dennis J.E., and Caplan A.I. Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2Kb-tsA58 transgenic mouse. J. Cell. Physiol. 167 (1996) 523-538
8. Dexter T.M., and Testa N.G. Differentiation and proliferation of hemopoietic cells in culture. Methods Cell Biol. 14 (1976) 387-405
9. Friedrich C., Zausch E., Sugrue S.P., and Gutierrez-Ramos J.C. Hematopoietic supportive functions of mouse bone marrow and fetal liver microenvironment: dissection of granulocyte, B-lymphocyte, and hematopoietic progenitor support at the stroma cell clone level. Blood 87 (1996) 4596-4606
10. Angelopoulou M., Novelli E., Grove J.E., Rinder H.M., Civin C., Cheng L., and Krause D.S. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp. Hematol. 31 (2003) 413-420
11. in 't Anker P.S., Noort W.A., Kruisselbrink A.B., Scherjon S.A., Beekhuizen W., Willemze R., Kanhai H.H., and Fibbe W.E. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp. Hematol. 31 (2003) 881-889
12. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., and Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101 (2003) 3722-3729
13. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., and Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75 (2003) 389-397
14. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., and Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106 (2005) 1755-1761
15. Ortiz L.A., Gambelli F., McBride C., Gaupp D., Baddoo M., Kaminski N., and Phinney D.G. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. USA 100 (2003) 8407-8411
16. Polchert D., Sobinsky J., Douglas G., Kidd M., Moadsiri A., Reina E., Genrich K., Mehrotra S., Setty S., Smith B., and Bartholomew A. IFN-γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur. J. Immunol. 38 (2008) 1745-1755
17. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craiq S., and Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
18. Rubinstein P., Rosenfield R.E., Adamson J.W., and Stevens C.E. Stored placental blood for unrelated bone marrow reconstitution. Blood 81 (1993) 1679-1690
19. Gotherstrom C., Ringden O., Westgren M., Tammik C., and Le Blanc K. Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells. Bone Marrow Transplant. 32 (2003) 265-272
20. Lee M.W., Choi J., Yang M.S., Moon Y.J., Park J.S., Kim H.C., and Kim Y.J. Mesenchymal stem cells from cryopreserved human umbilical cord blood. Biochem. Biophys. Res. Commun. 320 (2004) 273-278
21. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., and Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7 (2001) 211-228
22. Jang I.K., Ahn J.I., Shin J.S., Kwon Y.S., Ryu Y.H., Lee J.K., Park J.K., Song K.Y., Yang E.K., and Kim J.C. Transplantation of reconstructed corneal layer composed of corneal epithelium and fibroblasts on a lyophilized amniotic membrane to severely alkali-burned cornea. Artif. Organs 30 (2006) 424-431
23. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M., Du J., Aldrich S., Lisberg A., Low W.C., Larqaespada D.A., and Verfaillie C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418 (2002) 41-49
24. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., and Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30 (2002) 42-48
25. Ringdén O., Labopin M., Bacigalupo A., Arcese W., Schaefer U.W., Willemze R., Koc H., Bunjes D., Gluckman E., Rocha V., Schattenberg A., and Frassoni F. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J. Clin. Oncol. 20 (2002) 4655-4664
26. Jurgens W.J., Oedayrajsingh-Varma M.J., Helder M.N., Zandiehdoulabi B., Schouten T.E., Kuik D.J., Ritt M.J., and van Milligen F.J. Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell Tissue Res. 332 (2008) 415-426
27. Prockop D.J., Gregory C.A., and Spees J.L. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc. Natl. Acad. Sci. USA 100 Suppl. 1 (2003) 11917-11923
28. Terada N., Hamazaki T., Oka M., Hoki M., Mastalerz D.M., Nakano Y., Meyer E.M., Morel L., Petersen B.E., and Scott E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416 (2002) 542-545
29. Spees J.L., Olson S.D., Ylostalo J., Lynch P.J., Smith J., Perry A., Peister A., Wang M.Y., and Prockop D.J. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc. Natl. Acad. Sci. USA 100 (2003) 2397-2402
30. Augello A., Tasso R., Negrini S.M., Amateis A., Indiveri F., Cancedda R., and Pennesi G. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 35 (2005) 1482-1490
31. Djouad F., Plence P., Bony C., Tropel P., Apparailly F., Sany J., Noël D., and Jorgensen C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102 (2003) 3837-3844
32. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822
33. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., Galun E., and Rachmilewitz J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105 (2005) 2214-2219
34. Sato K., Ozaki K., Oh I., Meguro A., Hatanaka K., Nagai T., Muroi K., and Ozawa K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109 (2007) 228-234
35. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., and Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57 (2003) 11-20
36. Angoulvant D., Clerc A., Benchalal S., Galambrun C., Farre A., Bertrand Y., and Eljaafari A. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology 41 (2004) 469-476
37. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., and Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99 (2002) 3838-3843
38. Diez-Ruiz A., Tilz G.P., Zangerle R., Baier-Bitterlich G., Wachter H., and Fuchs D. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur. J. Haematol. 54 (1995) 1-8
39. Krampera M., Cosmi L., Angeli R., Pasini A., Liotta F., Andreini A., Santarlasci V., Mazzinghi B., Pizzolo G., Vinante F., Romagnani P., Maggi E., Romagnani S., and Annunziato F. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24 (2006) 386-398
40. Chan J.L., Tang K.C., Patel A.P., Bonilla L.M., Pierobon N., Ponzio N.M., and Rameshwar P. Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 107 (2006) 4817-4824
41. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., Brown C., and Mellor A.L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191-1193
42. Meisel R., Zibert A., Laryea M., Göbel U., Däubener W., and Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103 (2004) 4619-4621